Pharmacological effects of some newly developed soft anticholinergics and a receptor-binding QSAR study

被引:0
|
作者
Mori, N
Buchwald, P
Wu, WM
Ji, F
Hochhaus, G
Bodor, N
机构
[1] Univ Florida, Coll Pharm, Ctr Drug Discovery, Gainesville, FL 32610 USA
[2] IVAX, Miami, FL USA
来源
PHARMAZIE | 2006年 / 61卷 / 02期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Receptor-binding studies using cloned human muscarinic receptors (M-1-M-4 subtypes) were performed on newly synthesized soft anticholinergics (F-828, F-838, SGM, SGE, SA-A) that are isosteric/isoelectronic analogs of glycopyrrolate. The receptor binding pK(i) values of the new soft drugs were in the 5.5-9.5 range; with the majority being in the 7.0-8.5 range. As previously observed for similar structures, the pK(i) values tended to decrease with increasing molecular size, and with the introduction of three structural indicator variables, a QSAR equation accounting for close to 75% of the variability could be established. Confirming the known stereospecificity of these receptors, pure 2R isomers were found more active than the corresponding isomeric mixtures. In agreement with soft drug design principles, acid metabolites (SA-A) were found considerably less active than their parent esters. The more active, 2R isomer of SA-A showed some muscarinic subtype selectivity (M-3/M-2) which was not observed for the parent compounds of this zwitterionic metabolite. Guinea pig ileum assay pA(2) values have also been determined, and they were found to be in good agreement with the pK(i) values obtained from the binding study (r(2)=0.72). SGM and SGE caused pupil-dilation in rabbit eyes, but their mydriatic effects lasted considerably shorter than that of glycopyrrolate, and they did not induce dilation of the pupil in the contralateral, water-treated eyes, indicating that they are locally active and safe, with a low potential to cause systemic side effects.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [31] EFFECTS OF NEUROTENSIN ON DOPAMINE RECEPTOR-BINDING IN THE RAT STRIATUM
    YOSHIDA, T
    KITO, S
    MATSUBAYASHI, H
    MIYOSHI, R
    NEUROCHEMICAL RESEARCH, 1988, 13 (03) : 255 - 255
  • [32] EFFECTS OF BROMOCRIPTINE ON RECEPTOR-BINDING OF METHIONINE-ENKEPHALIN
    OGAWA, N
    YAMAWAKI, Y
    KURODA, H
    OFUJI, T
    NEUROSCIENCE LETTERS, 1981, 23 (02) : 215 - 218
  • [33] EFFECTS OF NEUROTENSIN ON DOPAMINE RECEPTOR-BINDING IN THE RAT STRIATUM
    KITO, S
    MIYOSHI, R
    TSUEMOTO, Y
    NITTA, K
    SHIMIZU, M
    MATSUBAYASHI, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P125 - P125
  • [34] THE EFFECTS OF CHRONIC HALOPERIDOL ADMINISTRATION ON GABA RECEPTOR-BINDING
    HUFFMAN, RD
    TICKU, MK
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (02) : 199 - 204
  • [35] SYNAPTOSOMAL GABA UPTAKE AND RECEPTOR-BINDING - EFFECTS OF A CONVULSION
    ESSMAN, EJ
    ESSMAN, WB
    BRAIN RESEARCH BULLETIN, 1980, 5 : 209 - 211
  • [36] THE EFFECTS OF IODINATION ON THE RECEPTOR-BINDING AFFINITY OF OVINE PROLACTIN
    RHODES, SB
    FRANTZ, WL
    HOLLAND, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 121 (02) : 686 - 694
  • [37] EFFECTS OF HALOPEMIDE ON GABA RECEPTOR-BINDING, UPTAKE AND RELEASE
    LOONEN, AJM
    SOEAGNIE, CJ
    SOUDIJN, W
    BRAIN RESEARCH, 1981, 210 (1-2) : 485 - 492
  • [38] SYNTHESIS AND RECEPTOR-BINDING OF SOME DIAMINE COMPOUNDS AS SIGMA-RECEPTOR LIGANDS
    ZHANG, Y
    BOWEN, WD
    WILLIAMS, W
    HE, XS
    DECOSTA, BR
    RICE, KC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 188 - MEDI
  • [39] EFFECTS OF MORPHINE ADMINISTRATION ON OPIATE RECEPTOR-BINDING IN MICE
    SIVAM, SP
    NABESHIMA, T
    HO, IK
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 289 - 289
  • [40] RECEPTOR-BINDING AND ELECTROPHYSIOLOGICAL EFFECTS OF DEHYDROEPIANDROSTERONE SULFATE, AN ANTAGONIST OF THE GABA(A) RECEPTOR
    DEMIRGOREN, S
    MAJEWSKA, MD
    SPIVAK, CE
    LONDON, ED
    NEUROSCIENCE, 1991, 45 (01) : 127 - 135